EMA Discusses European Clinical Trial Decline at DTRA
At the 2024 Decentralized Trials & Research Alliance (DTRA) Annual Meeting, Dr. Amir Kalali of the DTRA and Dr....
How Novartis is Using AI for Clinical Trial Feasibility and Site Selection
Novartis is at the forefront of modernizing clinical trial processes by integrating AI to enhance trial feasibility and site...
Strategic Navigation for Clinical Trials in Mid-Size Biopharma: Insights from Almirall
At SCOPE Summit Europe, Estrella García, PhD, an Executive Director at Almirall, shared her insights on navigating the complexities...
Bayer Transforms Clinical Trials with Digital Protocols
At the SCOPE EU conference, Julius Kusserow, an R&D Standards Expert at Bayer AG, presented a transformative vision for...
Addressing Clinical Trial Diversity: Challenges, Opportunities, and Critical Capabilities
The 2024 SCOPE Europe conference featured a presentation on clinical trial diversity, highlighting the critical need for diversity and...
Unleashing Patient Insights: Transforming Clinical Trials with Patient Perspectives
At SCOPE Summit Europe 2024, industry leaders gathered to explore the transformative potential of patient perspectives in decentralized clinical...
Roche Innovative Approach to Data-Driven Site Selection in Clinical Trials
In a groundbreaking presentation at SCOPE Europe 2024, Susannah Finney, Clinical Operations Lead and Product Owner at Roche, UK,...
AI and ML in Drug Development – A Deep Dive at DPHARM
The DPHARM conference brought together a panel of experts to discuss the transformative potential of Artificial Intelligence (AI) and...
Novartis Presents New Clinical Trial ALS Digital Health Biomarkers
At Panagora’s 7th Annual Digital Biomarkers in Clinical Trials Summit, Novartis presented a groundbreaking study on digital home-based assessments...
AI in Biopharmaceutical R&D: From Theory to Practice
At a recent conference, industry leaders gathered to explore the transformative potential of artificial intelligence (AI) in clinical trials,...